Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
Background and Objectives: Female pattern hair loss (FPHL) is a common form of scalp hair loss that occurs in 38% of females. Currently, minoxidil solution is the only therapy approved by the US Food and Drug Administration, but many other treatments are used, including cyproterone acetate, spironol...
Saved in:
Main Authors: | Alfredo Rossi, Francesca Magri, Andrea D'Arino, Flavia Pigliacelli, Marta Muscianese, Pierpaolo Leoncini, Gemma Caro, Alessandro Federico, Maria Caterina Fortuna, Marta Carlesimo |
---|---|
Format: | article |
Language: | EN |
Published: |
Mattioli1885
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/b1d78e3e6b3a4537b041b1d20fde700c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efectos adversos de finasteride: mitos y realidades. Una revisión actualizada
by: Carreño-Orellana,Néstor, et al.
Published: (2016) -
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
by: Kanamoto T, et al.
Published: (2012) -
Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
by: Irfan MM, et al.
Published: (2021) -
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
by: Turan-Vural E, et al.
Published: (2011) -
Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
by: Mizoguchi T, et al.
Published: (2017)